Comments on: Fangda Advises Genrix Bio on Exclusive Greater China Licensing Collaboration with YaoPharma for BCMA×CD3 Bispecific Antibody

Comments on: Fangda Advises Genrix Bio on Exclusive Greater China Licensing Collaboration with YaoPharma for BCMA×CD3 Bispecific Antibody /press-release/fangda-genrix-bio-yaopharma-greater-china-licensing-collaboration/ Tue, 09 Jun 2026 09:52:58 +0000 hourly 1